Project Details
Description
UTMB Team will evaluate antiviral activity of a candidate compound provided by EDCC using the transgenic mouse model hCD26/DPP-4.
| Status | Finished |
|---|---|
| Effective start/end date | 6/20/25 → 2/28/26 |
Funding
- Experimental Drug and Development Centre ( Award # ): $87,928.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.